A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 Hrs

NCT06708611 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Recruitment issues

Conditions

Heart Failure

Interventions

DRUG: torsemide

Sponsor

Sarfez Pharmaceuticals, Inc.